Prab: CSV import

2025-02-20T00:47:45Z

CSV import

← Older revision		Revision as of 00:47, 20 February 2025
Line 29:		Line 29:
	{{publishing-stub}}		{{publishing-stub}}
	{{medicine-stub}}		{{medicine-stub}}
			<gallery>
			File:BioMed Central 2018.svg\|BioMed Central 2018
			File:BioMed Central.svg\|BioMed Central
			</gallery>

Prab: CSV import

2024-03-10T19:45:13Z

CSV import

New page

'''BioMed Central''' is an [[open access]] publisher that produces [[scientific literature]] under an open license, allowing anyone to access, use, distribute, and build upon the research. It was established in the United Kingdom in 2000 and has since become a significant force in the [[scientific publishing]] industry.

== History ==
BioMed Central was founded in 2000 by [[Vitek Tracz]], a pioneer in the field of open access publishing. The company was initially a part of the Current Science Group (now known as the Science Navigation Group), but was acquired by [[Springer Science+Business Media]] in 2008. In 2015, Springer became part of the larger [[Springer Nature]] group, which continues to operate BioMed Central as a separate entity.

== Business Model ==
BioMed Central operates on a [[business model]] that differs significantly from traditional scientific publishing. Instead of charging readers and libraries for access to articles, BioMed Central charges authors a publication fee upon the acceptance of their manuscript. This model, known as the [[author-pays model]], ensures that all research published by BioMed Central is freely available to the public.

== Journals ==
BioMed Central publishes over 290 peer-reviewed [[journal|journals]] across all areas of biology, biomedicine, and medicine. These include the ''[[BMC series]]'', a group of open access, peer-reviewed journals that span the fields of biology and medicine. Other notable journals include ''[[Genome Biology]]'', ''[[Malaria Journal]]'', and ''[[Arthritis Research & Therapy]]''.

== Impact ==
BioMed Central has had a significant impact on the scientific publishing industry. It has been a major proponent of the open access movement, which advocates for free and unrestricted access to research. This has led to a shift in the way scientific research is disseminated and accessed, with many other publishers following BioMed Central's lead in offering open access options.

== Criticism ==
Despite its successes, BioMed Central has faced criticism. Some have questioned the quality of the peer review process in open access publishing, and there have been instances of BioMed Central retracting articles due to issues such as plagiarism and data fabrication. However, the company has implemented strict [[peer review]] policies and ethical guidelines to address these concerns.

== See Also ==
* [[Open access (publishing)]]
* [[Scientific publishing]]
* [[Springer Nature]]
* [[Author-pays model]]

[[Category:Open access (publishing)]]
[[Category:Scientific publishing]]
[[Category:Springer Nature]]
[[Category:BioMed Central]]

{{publishing-stub}}
{{medicine-stub}}

BioMed Central - Revision history

Prab: CSV import

Prab: CSV import